Using health state utility values from the general population to approximate baselines in decision analytic models when condition specific data are not available
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Janel Hanmer & William F. Lawrence & John P. Anderson & Robert M. Kaplan & Dennis G. Fryback, 2006. "Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores," Medical Decision Making, , vol. 26(4), pages 391-400, July.
- Dennis G. Fryback & William F. Lawrence JR, 1997. "Dollars May Not Buy as Many QALYs as We Think:," Medical Decision Making, , vol. 17(3), pages 276-284, July.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Malek B Hannouf & Chander Sehgal & Jeffrey Q Cao & Joseph D Mocanu & Eric Winquist & Gregory S Zaric, 2012. "Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer," PLOS ONE, Public Library of Science, vol. 7(6), pages 1-9, June.
- Malek Ebadi & Raha Akhavan-Tabatabaei, 2021. "Personalized Cotesting Policies for Cervical Cancer Screening: A POMDP Approach," Mathematics, MDPI, vol. 9(6), pages 1-20, March.
- Bleichrodt, Han & Crainich, David & Eeckhoudt, Louis, 2003.
"Comorbidities and the willingness to pay for health improvements,"
Journal of Public Economics, Elsevier, vol. 87(11), pages 2399-2406, October.
- BLEICHRODT, Han & CRAINICH, David & EECKHOUDT, Louis, 2003. "Comorbidities and the willingness to pay for health improvements," LIDAM Reprints CORE 1699, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Lin Li & J L (Hans) Severens & Olena Mandrik, 2019. "Disutility associated with cancer screening programs: A systematic review," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-17, July.
- Prajakta P. Masurkar & Haluk Damgacioglu & Ashish A. Deshmukh & Meghana V. Trivedi, 2023. "Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer in Postmenopausal Women in the USA," PharmacoEconomics, Springer, vol. 41(6), pages 709-718, June.
- Amber Pearson & Gregory Breetzke, 2014. "The Association Between the Fear of Crime, and Mental and Physical Wellbeing in New Zealand," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 119(1), pages 281-294, October.
- James K. Hammitt, 2017.
"Valuing Non-Fatal Health Risks: Monetary and Health-Utility Measures,"
Revue économique, Presses de Sciences-Po, vol. 68(3), pages 335-356.
- Hammitt, James K., 2017. "Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures," TSE Working Papers 17-757, Toulouse School of Economics (TSE).
- Andrea C Villanti & Yiding Jiang & David B Abrams & Bruce S Pyenson, 2013. "A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-11, August.
- Mehmet A. Ergun & Ali Hajjar & Oguzhan Alagoz & Murtuza Rampurwala, 2022. "Optimal breast cancer risk reduction policies tailored to personal risk level," Health Care Management Science, Springer, vol. 25(3), pages 363-388, September.
- Iris Buder & Cathleen Zick & Norman Waitzman, 2020. "The Contribution of Physical Activity to Health-Related Quality of Life: New Population Estimates from National Survey Data," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 15(1), pages 55-71, March.
- Bleichrodt, Han & Herrero, Carmen & Pinto, Jose Luis, 2002. "A proposal to solve the comparability problem in cost-utility analysis," Journal of Health Economics, Elsevier, vol. 21(3), pages 397-403, May.
- Janel Hanmer & Barry Dewitt & Lan Yu & Joel Tsevat & Mark Roberts & Dennis Revicki & Paul A Pilkonis & Rachel Hess & Ron D Hays & Baruch Fischhoff & David Feeny & David Condon & David Cella, 2018. "Cross-sectional validation of the PROMIS-Preference scoring system," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-13, July.
- James Hammitt & Tuba Tunçel, 2015. "Preferences for life-expectancy gains: Sooner or later?," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 79-101, August.
- Bleichrodt, Han & Crainich, David & Eeckhoudt, Louis, 2003.
"The effect of comorbidities on treatment decisions,"
Journal of Health Economics, Elsevier, vol. 22(5), pages 805-820, September.
- BLEICHRODT, Han & CRAINICH, David & EECKHOUDT, Louis, 2003. "The effect of comorbidities on treatment decisions," LIDAM Reprints CORE 1668, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Martijn S Visser & Sankha Amarakoon & Tom Missotten & Reinier Timman & Jan J Busschbach, 2017. "SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-9, February.
- Ali Hajjar & Oguzhan Alagoz, 2023. "Personalized Disease Screening Decisions Considering a Chronic Condition," Management Science, INFORMS, vol. 69(1), pages 260-282, January.
- Felder, Stefan & Mayrhofer, Thomas, 2011. "Higher-Order Risk Preferences – Consequences for Test and Treatment Thresholds and Optimal Cutoffs," Ruhr Economic Papers 287, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
- Rakesh Aggarwal & Qiushi Chen & Amit Goel & Nicole Seguy & Razia Pendse & Turgay Ayer & Jagpreet Chhatwal, 2017. "Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-15, May.
- Mickaël Hiligsmann & Stuart S. Silverman & Andrea J. Singer & Leny Pearman & Jake Mathew & Yamei Wang & John Caminis & Jean-Yves Reginster, 2023. "Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States," PharmacoEconomics, Springer, vol. 41(7), pages 819-830, July.
- Laura McCullagh & Cathal Walsh & Michael Barry, 2012. "Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting," PharmacoEconomics, Springer, vol. 30(10), pages 941-959, October.
More about this item
Keywords
health state utility values; baseline; quality of life; EQ-5D; age-adjusted;All these keywords.
JEL classification:
- I31 - Health, Education, and Welfare - - Welfare, Well-Being, and Poverty - - - General Welfare, Well-Being
- I19 - Health, Education, and Welfare - - Health - - - Other
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:29946. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Joachim Winter (email available below). General contact details of provider: https://edirc.repec.org/data/vfmunde.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.